Direct Gene Knock-out of Axolotl Spinal Cord Neural Stem Cells via Electroporation of CAS9 Protein-gRNA Complexes
July 9th, 2019
7.5K views
Presented here is a protocol to perform time- and space-restricted gene knock-out in axolotl spinal cords by injecting CAS9-gRNA complex into the spinal cord central canal followed by electroporation.
Overview
This protocol allows rapid and highly-penetrating time and space-restricted gene knock-outs in axolotl spinal cord neural stem cells for the study of the molecular mechanisms of spinal cord regeneration. Understanding regeneration mechanisms could lead to insights for developing treatments for human spinal cord injury.
Key Study Components
Area of Science
- Neuroscience
- Regenerative Biology
- Gene Editing
Background
- Axolotl neural stem cells contribute largely to their ability to regenerate their spinal cords.
- This technique allows the study of gene function in neural stem cells without confounding developmental effects.
- Correctly positioning the injection capillary into the spinal cord central column can be challenging.
- Practicing on test animals helps master the technique.
Purpose of Study
- To perform time- and space-restricted gene knock-out in axolotl spinal cords.
- To study the molecular mechanisms of spinal cord regeneration.
- To gain insights for developing treatments for human spinal cord injury.
Methods Used
- Injection of CAS9-gRNA complex into the spinal cord central canal.
- Electroporation to facilitate gene knock-out.
- Use of axolotl neural stem cells for regeneration studies.
- Practicing on test animals to refine technique.
Main Results
- Successful gene knock-outs in axolotl spinal cord neural stem cells.
- Insights into the regenerative response of axolotl neural stem cells.
- Demonstrated the feasibility of the technique for studying gene function.
- Provided a method to investigate spinal cord injury mechanisms.
Conclusions
- This method enhances understanding of spinal cord regeneration in axolotls.
- It offers potential pathways for developing human spinal cord injury treatments.
- Further studies can build on this technique to explore gene functions.
Frequently Asked Questions
What is the significance of axolotl neural stem cells?
Axolotl neural stem cells play a crucial role in their ability to regenerate spinal cords, making them an important model for studying regeneration.
How does the CAS9-gRNA complex work?
The CAS9-gRNA complex is used to target and edit specific genes, allowing researchers to study the effects of gene knock-outs.
What challenges are associated with this technique?
Correctly positioning the injection capillary can be challenging, which is why practicing on test animals is recommended.
What are the potential applications of this research?
This research could lead to new treatments for human spinal cord injuries by understanding the mechanisms of regeneration in axolotls.
Is this technique applicable to other species?
While this protocol is designed for axolotls, similar techniques may be adapted for use in other species with regenerative capabilities.
What insights can be gained from studying gene function in neural stem cells?
Studying gene function in neural stem cells can reveal critical information about the processes involved in spinal cord regeneration and repair.
Executive Industry Relevance
This protocol enables time- and space-restricted gene knock-out in axolotl spinal cord neural stem cells, providing a controlled system to study regeneration mechanisms without developmental confounders. It supports target validation and mechanistic de-risking in regenerative biology by linking specific gene functions to spinal cord repair processes. Insights gained may inform therapeutic target identification for human spinal cord injury through comparative pathway analysis.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses in neural stem cells by knocking out candidate genes to assess functional relevance in regeneration.
- Operational Value: Provides spatially and temporally controlled gene perturbation, reducing variability from developmental or off-target effects.
- Predictive Value: Supports target confidence by demonstrating phenotype-genotype links in a disease-relevant regenerative model.
Screening & Assay Development
- Scientific Value: Generates quantifiable molecular readouts (e.g., immunoreactivity loss, genotyping) to assess knock-out efficiency and phenotypic impact.
- Operational Value: Standardizes delivery via electroporation and capillary injection, enabling reproducible preparation of gene-edited neural stem cell populations.
- Scalability: Facilitates multi-gene knock-out studies (e.g., Sox2 and GFP) to evaluate combinatorial target effects in parallel.
Translational & Preclinical Research
- Disease Relevance: Uses axolotl spinal cord regeneration as a model to explore conserved mechanisms applicable to mammalian injury response.
- Translational Continuity: Connects gene function in neural stem cells to structural recovery, supporting biomarker-aligned target selection.
- Mechanistic De-risking: Clarifies causal roles of targets in regeneration, reducing ambiguity in preclinical target selection.
Pipeline & Workflow Integration
The method fits within early discovery to preclinical workflows by enabling functional gene validation in a regenerative context prior to target prioritization.
- Discovery Biology: Supports hypothesis testing and pathway clarification by isolating gene function in injury-responsive neural stem cells.
- Screening: Delivers assay-ready models with quantifiable editing efficiency for compound or genetic screening applications.
- Analytics: Provides protein-level (immunohistochemistry) and DNA-level (PCR/sequencing) outputs to quantify editing and correlate with phenotype.
- Translational Research: Links neural stem cell activity to tissue-level regeneration, informing preclinical target validation.
- Enterprise Reuse: Establishes a reusable platform for iterative gene perturbation studies in spinal cord regeneration models.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence in target validation through direct phenotype observation in regenerative neural stem cells.
- Operational Value: Standardized, reproducible gene knock-out with spatial and temporal control across experimental batches.
- Strategic Value: Informs go/no-go decisions by reducing mechanistic ambiguity in target pathways.
- Portfolio Impact: Enables risk-adjusted target prioritization based on functional validation in a regeneration-competent system.
Implementation Considerations
- Expertise in microsurgery, capillary preparation, and electrophysiology for accurate central canal targeting.
- Instrumentation for microinjection, electroporation, fluorescence imaging, and molecular analysis (PCR, sequencing, immunohistochemistry).
- Standardization of injection mix preparation, electroporation parameters, and animal handling across users and sites.
- Adaptation considerations for different axolotl ages, injury models, or transgenic reporter lines.
- Practical limitations include technical difficulty in capillary placement and variability in electroporation efficiency requiring training and optimization.
Biopharma FAQs
Why is null hypothesis testing important for validating gene knock-out efficiency?
Null hypothesis testing determines whether observed reductions in target protein (e.g., Sox2) or genetic editing rates are statistically significant compared to controls, ensuring that phenotypic changes are due to the knock-out and not experimental variability. This supports confident target validation in regenerative studies.
How does isolating the independent variable (gene knock-out) improve target validation in discovery pipelines?
By restricting Cas9-gRNA delivery to specific spinal cord regions and timepoints, the method isolates the effect of gene loss from developmental or systemic confounders, enabling clear attribution of phenotypic changes to the targeted gene. This strengthens causal inference in early target validation.
What quantitative dependent variable measurements enable assessment of knock-out success?
Quantitative measurements include immunoreactivity loss (e.g., Sox2-positive cell counts), genotyping via PCR and Sanger/next-generation sequencing to determine editing percentage, and phenotypic scoring of neural stem cell populations. These provide objective, scalable readouts for knock-out efficiency.
Why are replication requirements critical for cross-functional collaboration in target validation?
Replication ensures that gene knock-out efficiency and phenotypic outcomes are consistent across animals, operators, and experimental batches, which is essential for reliable data sharing between discovery, screening, and preclinical teams. Standardized protocols and training reduce variability and support collaborative decision-making.
What statistical analysis capabilities are required before implementing this knock-out method in a discovery workflow?
Implementation requires capability to perform statistical comparisons (e.g., t-tests, ANOVA) between control and knock-out groups for protein expression or editing frequency, along with power analysis to determine sample sizes needed to detect biologically relevant effects. These analyses support data-driven go/no-go decisions in target validation pipelines.
Chapters in this video
0:04
Title
1:16
CAS9-gRNA Ribonucleoprotein Mixture and Agarose Plate Preparation
2:33
Electroporator Configuration and Glass Microinjection Capillary Loading
4:09
Pneumatic Pump Configuration
4:37
CAS9-gRNA Ribonucleoprotein Mixture Injection
6:05
Electroporation
6:45
Knock-Out Efficiency Assessment
7:25
Results: Representative Knock-Out Effects in Axolotl Spinal Cord Neural Stem Cells
8:33
Conclusion
